Enable Patient-Centric, Paperless Clinical Trials
Go paperless and deliver a better patient experience with MyVeeva for Patients.
MyVeeva for Patients is a new application that clinical research sites can use to digitally connect with research patients.
With capabilities for eConsent, virtual visits, patient adherence, and ePRO, MyVeeva gives sites more flexibility and makes it easier for patients to participate in clinical trials.
MyVeeva for Patients is free for clinical research sites and is available for early adopters starting in February 2021.
Improve the Research Experience for Patients
Collaborate with patients remotely to reduce patient burden and improve satisfaction.
Streamline Study and Participant Management
Reduce redundancy and simplify the delivery, collection, filling, and storage of patient-related information.
Free for Sites
Engage virtually with your patients across all of your studies at no cost with a system that you own and control.
MyVeeva for Patients is Planned to Include:
eConsent
Easily share information and collect patient consent electronically with less time and effort. Allow patients to use their own device to provide consent for improved convenience. Now available for early adopters.
Virtual Visits
Collaborate remotely with audio and video capabilities, allowing seamless communication between sites and patients.
ePRO
Replace paper questionnaires by allowing patients to report on treatment outcomes electronically, from their own mobile device.
Patient Adherence
Help patients take medications and adhere to their treatment regimens. Send reminders to patients about study activities to support protocol compliance.
Integrate with Veeva SiteVault
Connect seamlessly with Veeva SiteVault to reduce redundancy across studies and patients.
Deliver a better patient experience while creating efficiencies for your site.
Veeva eConsent is a new way of thinking about the consenting process for patients – and it’s free for sites.
Break free from legacy tools and long paper documents, give your patients access to a modern digital consent experience that fits into their daily lives.
